Roda, Ryle Jetron B.
HRN: 22-41-85 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/30/2024
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
12/29/2024
01/05/2025
ORAL
5 Ml
Every 8 Hours
Intestinal Amoebiasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes